The apparently contradictory finding of lower CML/Alb in subjects presenting cardiometabolic risk factors probably reflects trapping of lipophilic CML into fat tissue, resulting in low levels of circulating CML in obese subjects [68, 69]. The gene discussed is ALB; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.